SRSF3 has been shown to interact with two additional splicing factors, polypyrimidine tract binding protein 1 (PTBP1), and polypyrimidine tract binding protein 2 (PTBP2), which promote glioma cell motility. The gene discussed is PTBP2; the disease is central nervous system cancer.